Tumor‐associated antigen TA‐90 immune complex assay predicts subclinical metastasis and survival for patients with early stage melanoma
暂无分享,去创建一个
D. Morton | L. Wanek | M. Kelley | S. Stern | Rishab K. Gupta | Ralph C. Jones | R. Yee
[1] J. Hansson. Systemic therapy of malignant melanoma , 1997, Medical oncology.
[2] J. Kirkwood,et al. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] D. Morton,et al. Vaccine therapy for malignant melanoma , 1996, CA: a cancer journal for clinicians.
[4] C. Balch,et al. Finally, a successful adjuvant therapy for high-risk melanoma. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[5] D. Schadendorf,et al. Serum manganese superoxide dismutase is a new tumour marker for malignant melanoma , 1995, Melanoma research.
[6] K. Wakamatsu,et al. Evaluation of melanin‐related metabolites as markers of melanoma progression , 1994, Cancer.
[7] D L Morton,et al. Multivariate analysis of the relationship between survival and the microstage of primary melanoma by clark level and breslow thickness , 1993, Cancer.
[8] D L Morton,et al. Technical details of intraoperative lymphatic mapping for early stage melanoma. , 1992, Archives of surgery.
[9] D. Morton,et al. Monoclonal antibody‐based ELISA to detect glycoprotein tumor‐associated‐antigen‐specific immune complexes in cancer patients , 1992, Journal of clinical laboratory analysis.
[10] R. Gupta,et al. Characterization of a 90‐100 kDa tumor‐associated antigen in the sera of melanoma patients , 1990, International journal of cancer.
[11] A. Cochran,et al. Occult Tumor Cells in the Lymph Nodes of Patients with Pathological Stage I Malignant Melanoma An Immunohistological Study , 1988, The American journal of surgical pathology.
[12] R. Gupta. Circulating immune complexes in malignant melanoma. , 1988, Disease markers.
[13] J. Morote Robles. [What...about tumor markers]. , 1988, Actas urologicas espanolas.
[14] C. Balch,et al. A Comparison of Prognostic Factors and Surgical Results in 1,786 Patients with Localized (Stage I) Melanoma Treated in Alabama, USA, and New South Wales, Australia , 1982, Annals of surgery.
[15] M. Mihm,et al. Prognostic Factors for Patients with Clinical Stage I Melanoma of Intermediate Thickness (1.51–3.99 mm)* A Conceptual Model for Tumor Growth and Metastasis , 1982 .
[16] R. Gupta,et al. Tumor-associated antigens detected by autologous sera in urine of patients with solid neoplasms. , 1980, The Journal of surgical research.